Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
Scroll Up
Scroll Down

The EU Definition of Nanomaterial – Potential Measurement Methodologies
Bookmark and Share

NanoSight Limited

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.  

The definition has these principal elements:  

• Counting particles defines nanomaterials: The material is a nanomaterial if more than 50% of particles have at least one dimension between 1nm and 100nm.  

• Alternatively, it is also a nanomaterial if it has a specific surface per unit volume of greater than 60 m2/cm3.  

• There are specific inclusions such as graphene.  

• Naturally occurring and incidental materials are included, as well as manufactured particles.  

• Aggregates and agglomerates of such particles are included.  

No measurement methods are specified; the recommendation is ‘best available alternative methods should be applied. This definition is   not regulation, however its EU provenance informs its authority. For many regulators within the EU, this definition is the missing jigsaw piece to slot into potential regulation of publically-driven and government-derived legislation, covering nanomaterial matters from manufacture, labelling and handling, through transport and environmental fate. The FP7 project ObservatoryNANO describes current legislative work in their 4th report, April 2012. 

Further Information

Related Content

Caltech Uses NTA to Characterize New Therapeutic Nanoparticles
Caltech to study nanoparticle-based therapeutics for the treatment of dementia, Parkinson's and Alzheimer's diseases.
Wednesday, May 01, 2013
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!